Robbins llp reminds investors of the cassava sciences, inc. (sava) class action and urges investors with large losses to contact the firm for information

San diego, jan. 02, 2025 (globe newswire) -- robbins llp reminds investors that a class action was filed against cassava sciences, inc. (nasdaq: sava) for wrongdoing between february 7, 2024 and november 24, 2024. cassava is a clinical stage biotechnology company, with a focus on developing drugs for neurodegenerative diseases.
SAVA Ratings Summary
SAVA Quant Ranking